Browse our comprehensive collection of market intelligence reports.
The market is characterized by a structural shift toward outsourcing across the drug development lifecycle, particularly in oncology, where technical barriers and regulatory scrutiny are significantly higher. Pharmaceutical and biotechnology companies are prioritizing flexibility, speed, and cost optimization, making CDMOs integral partners rather than transactional service providers. This evolution is particularly evident in biologics manufacturing, where specialized expertise in monoclonal
The medical gas and equipment market supplies critical gases and delivery systems, which enable healthcare facilities to deliver patient care, perform surgical operations, diagnostic tests, and pharmaceutical work. The sector provides essential support for life-saving respiratory treatments and anesthesia procedures while delivering exact gas control and treatment for increasing chronic respiratory disease, an aging population, and growing home healthcare needs. The sector shifts from traditi
The Israeli protective clothing sector operates as a strategic extension of the national security and high-tech manufacturing ecosystem. Demand drivers are shifting as defense protocols adapt to asymmetrical threats, requiring lighter but more resilient ballistic and chemical-biological-radiological-nuclear (CBRN) gear. National dependency on localized production remains high due to the necessity for immediate fulfillment during regional escalations and the unique requirements of the Israel D
The Indonesian peanut butter market operates as a vital segment of the broader spreads and condiments industry, characterized by a deep dependency on both localized peanut production and strategic imports to satisfy urban demand. Structural demand drivers revolve around the "westernization" of Indonesian breakfast habits and the expanding middle-class preference for ready-to-consume, shelf-stable protein sources. Regulatory influence from the Badan Pengawas Obat dan Makanan (BPOM) and mandato
The global dental biomaterial market is expected to grow at a CAGR of 9.21% over the forecast period to reach a total market size of US$18.801 billion by 2030, increasing from US$12.102 billion in 2025. Dental biomaterials include all types of natural and biocompatible synthetic materials used to restore damaged and decayed teeth.
Engineered probiotic therapeutics redefine microbiome intervention by shifting from passive supplementation toward programmable biological function. Demand is moving from generalized gut health products toward strain-specific, gene-edited microbial therapies targeting disease pathways. Clinical pipelines are expanding as synthetic biology tools are enabling precision modulation of host–microbe interactions. Regulatory bodies are tightening classification frameworks, which is increasing develo
Chemotherapy remains a standard-of-care modality across multiple cancer types, often used as first-line, adjuvant, or neoadjuvant therapy. The market is undergoing a gradual transformation as chemotherapy is increasingly combined with immunotherapy and targeted agents, enhancing treatment outcomes. This shift is redefining the role of chemotherapy from standalone therapy to a synergistic component within multi-modal treatment strategies. Such combinations are particularly prominent in lung an
The market is undergoing a structural transition from traditional lab-based diagnostics to rapid, decentralized testing solutions that can deliver actionable results within minutes to hours. This shift is particularly impactful in oncology, where early detection and timely therapeutic intervention directly influence survival rates. The integration of molecular diagnostics into point-of-care settings is a key trend, allowing clinicians to detect genetic mutations and biomarkers without requiri
The MRD testing landscape is evolving from research-centric applications to routine clinical use, particularly in oncology care pathways. The integration of MRD testing into treatment decision-making is transforming how remission and relapse risks are assessed. Technologies such as next-generation sequencing are enabling ultra-sensitive detection, while liquid biopsy approaches are reducing reliance on invasive procedures, thereby improving patient compliance and testing frequency.A ke
The Exosome Diagnostics Market is characterized by a strong shift toward liquid biopsy-based solutions, where exosomes are gaining prominence as stable and information-rich biomarkers. Unlike circulating tumor DNA, exosomes provide both genomic and proteomic insights, enabling more comprehensive disease profiling. This trend is particularly impactful in oncology, where early detection and real-time monitoring are critical for improving patient outcomes. The increasing preference for minimally
The cancer nutrition market is evolving from a supportive care niche into a core component of oncology treatment pathways. A key trend is the increasing personalization of nutrition plans based on cancer type, stage, and patient metabolic needs. Clinicians are increasingly adopting tailored nutritional regimens that address cachexia, immune suppression, and gastrointestinal complications associated with cancer therapies. This shift is transforming nutrition from a generalized supplement appro
The CGM market in Indonesia in 2025 was influenced by the high volume of diabetes in Indonesia and the ongoing government efforts to manage the burden of non-communicable diseases (NCD) through the Ministry of Health. The Ministry of Health's own statistics for Indonesia show that there is a high prevalence of diabetes in the country, but that a great deal of this population is undiagnosed, hence a substantial gap in early detection and an ongoing process for managing the diabetes population.